 This is an open-label, 2-cycle, multiple-dose, single-sequence study in women of child-bearing potential. The primary objective is to assess the effect of BMS-986142 on the pharmacokinetics PK of Combined Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone Acetate. 